Search

Your search keyword '"King, C. A."' showing total 7,280 results

Search Constraints

Start Over You searched for: Author "King, C. A." Remove constraint Author: "King, C. A."
7,280 results on '"King, C. A."'

Search Results

1. In-Flight Performance of Spider's 280 GHz Receivers

3. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

7. Conceptual Design of the Modular Detector and Readout System for the CMB-S4 survey experiment

8. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype

11. A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

12. Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection

13. A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.

14. A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

15. Scholarly Communication and Peer Review: Moving towards Utopia. Research & Occasional Paper Series: CSHE.4.19

17. A History of Berkeley Chemical Engineering: Pairing Engineering and Science

18. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

19. Oxygen-16 Spectrum from Tetrahedral Vibrations and their Rotational Excitations

20. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

21. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

22. A PKA inhibitor motif within SMOOTHENED controls Hedgehog signal transduction

23. Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230

24. Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

25. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

26. POS1200 MRT-6160, A VAV1-DIRECTED MOLECULAR GLUE DEGRADER, REDUCES JOINT INFLAMMATION, CYTOKINE PRODUCTION, AND AUTOANTIBODY LEVELS IN A COLLAGEN-INDUCED ARTHRITIS DISEASE MODEL

27. P228 Multicentre reviewof lung microbiome for patients with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

28. The University of California: Creating, Nurturing, and Maintaining Academic Quality in a Public University Setting

29. Involutions and the Gelfand character

30. Characterizing Fatigue Subtypes in Adolescents with Chronic Musculoskeletal Pain and Pain-Free Controls

31. Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults

32. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

38. In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

40. Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma

41. Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross stage recognition of glutamate-rich repeats

49. Mutant clones in normal epithelium outcompete and eliminate emerging tumours

50. The Need for an International Geoscience School Syllabus: Its Development and Publication

Catalog

Books, media, physical & digital resources